Compare FRMI & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRMI | ICUI |
|---|---|---|
| Founded | 2025 | 1984 |
| Country | United States | United States |
| Employees | 35 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.6B |
| IPO Year | N/A | 1995 |
| Metric | FRMI | ICUI |
|---|---|---|
| Price | $6.24 | $166.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $26.13 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 18.6M | 267.1K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | N/A | ★ 1.20 |
| Revenue | N/A | ★ $2,231,262,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $120.76 | $4.46 |
| P/E Ratio | ★ N/A | $143.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.47 | $107.02 |
| 52 Week High | $32.39 | $176.27 |
| Indicator | FRMI | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 60.65 |
| Support Level | $5.52 | $139.88 |
| Resistance Level | $7.34 | N/A |
| Average True Range (ATR) | 0.61 | 4.60 |
| MACD | -0.03 | 0.40 |
| Stochastic Oscillator | 40.79 | 60.65 |
Fermi Inc building a private power campus for AI-centric customers, developing and leasing large-scale, grid-independent energy generation and high-performance computing facilities purpose-built for the hyperscale era. The company is also developing a private energy and site infrastructure platform across the campus to support multiple powered shell buildings and a diversified, integrated power supply, including private power generation and delivery infrastructure, substations, internal distribution networks, water and cooling systems, and other essential infrastructure. In addition to powered shell facilities, it may offer long-term ground leases to tenants that elect to construct their own powered shell facilities on land, with or without integrated power delivery.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.